ARTICLE | Clinical News
BioSpecifics, Tufts University regulatory update
June 14, 1999 7:00 AM UTC
The parties jointly received U.S. Patent No. 5,851,522 covering an enzyme formulation consisting of the collagenase enzyme and the hbEGF growth factor as a wound healing agent. ...